Patents by Inventor Laurent Bellon

Laurent Bellon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR MOLECULAR INVERSION PROBE ASSAYS
    Publication number: 20240093275
    Abstract: The invention provides methods and compositions to enhance the efficiency and sensitivity of molecular inversion probe (MIP) reactions. Probes include elements that allow MIP ends to abut for ligation while avoiding the possibility of polymerase strand displacement errors. Elements facilitate multiplexed detections, including MIP reaction product detections employing next generation sequencing (NGS) techniques.
    Type: Application
    Filed: September 8, 2023
    Publication date: March 21, 2024
    Inventors: Michael H. SHAPERO, Lawrence GREENFIELD, Ronald J. SAPOLSKY, Keith JONES, Laurent BELLON, Robert J. LIPSHUTZ, August ESTABROOK, John EFCAVITCH
  • LANDING DEVICE FOR DISMOUNTING FROM APPARATUS, PARTICULARLY FOR GYMNASTS
    Publication number: 20190118020
    Abstract: The object of the invention is a landing device, particularly for gymnasts when dismounting from said apparatus, particularly for the purpose of a stabilized dismount, characterized in that it comprises at least one first shock-absorbing volume (10) and one second shock-absorbing volume (12), the at least one of these two volumes being inflatable, both superimposed, as well as means (14) of connecting these at least two volumes in said superimposed position. The second shock-absorbing volume is inflatable.
    Type: Application
    Filed: June 13, 2017
    Publication date: April 25, 2019
    Applicant: PISTE GONFLABLE.COM
    Inventor: Laurent Bellon
  • Compositions and Methods for Molecular Inversion Probe Assays
    Publication number: 20150284786
    Abstract: The invention provides methods and compositions to enhance the efficiency and sensitivity of molecular inversion probe (MIP) reactions. Probes include elements that allow MIP ends to abut for ligation while avoiding the possibility of polymerase strand displacement errors. Elements facilitate multiplexed detections, including MIP reaction product detections employing next generation sequencing (NGS) techniques.
    Type: Application
    Filed: April 3, 2015
    Publication date: October 8, 2015
    Inventors: Michael H. Shapero, Lawrence Greenfield, Ronald J. Sapolsky, Keith Jones, Laurent Bellon, Robert J. Lipshutz, August Estabrook, John Efcavitch
  • Chemically modified double stranded nucleic acid molecules
    Publication number: 20050176018
    Abstract: This invention relates to novel chemically-modified nucleic acid molecules having specified formulae that exhibit increased resistance to nucleases and increased binding affinity to target nucleic acid molecules. The invention further relates to methods of modulating gene expression using the novel chemically modified nucleic acid molecules, and compositions and cells comprising said molecules.
    Type: Application
    Filed: November 17, 2003
    Publication date: August 11, 2005
    Applicant: Sirna Therapeutics, Inc.
    Inventors: James Thompson, Leonid Beigelman, James McSwiggen, Alexander Karpeisky, Laurent Bellon, Mark Reynolds, Michael Zwick, Thale Jarvis, Tod Woolf, Peter Haeberli, Jasenka Matulic-Adamic
  • Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
    Patent number: 6673611
    Abstract: This invention relates to novel chemically-modified nucleic acid molecules having specific formulae that exhibit increased resistance to nucleases and increased binding affinity to target nucleic acid molecules. The invention further relates to methods of modulating gene expression using the novel chemically modified nucleic acid molecules, and compositions and cells comprising said molecules.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: January 6, 2004
    Assignee: Sirna Therapeutics, Inc.
    Inventors: James Thompson, Leonid Beigelman, James McSwiggen, Alexander Karpeisky, Laurent Bellon, Mark Reynolds, Michael Zwick, Thale Jarvis, Tod Woolf, Peter Haeberli, Jasenka Matulic-Adamic
  • Deprotection of RNA
    Patent number: 6673918
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: January 6, 2004
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman
  • Method for screening nucleic acid catalysts
    Publication number: 20030170644
    Abstract: Nucleic acid catalysts, method of screening for variants of nucleic acid catalysts, synthesis of ribozyme libraries and discovery of gene sequences are described.
    Type: Application
    Filed: March 29, 2002
    Publication date: September 11, 2003
    Applicant: Ribozyme Pharmaceuticals, Inc.
    Inventors: Alex Burgin, Leonid Beigelman, Laurent Bellon
  • Method for screening nucleic acid catalysts
    Publication number: 20030144489
    Abstract: Nucleic acid catalysts, method of screening for variants of nucleic acid catalysts, synthesis of enzymatic nucleic acid molecule libraries and discovery of gene sequences are described.
    Type: Application
    Filed: May 28, 2002
    Publication date: July 31, 2003
    Inventors: Alex Burgin, Leonid Beigelman, Laurent Bellon, Shawn Zinnen
  • Method for screening nucleic acid catalysts
    Patent number: 6548657
    Abstract: Nucleic acid catalysts, method of screening for variants of nucleic acid catalysts, synthesis of ribozyme libraries and discovery of gene sequences are described.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: April 15, 2003
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Alex Burgin, Leonid Beigelman, Laurent Bellon
  • Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
    Publication number: 20020142980
    Abstract: The invention features nucleic acid molecules with novel combinations of chemical modifications which are able to modulate gene expression.
    Type: Application
    Filed: May 25, 2001
    Publication date: October 3, 2002
    Inventors: James Thompson, Leonid Beigelman, James McSwiggen, Alexander Karpeisky, Laurent Bellon, Mark Reynolds, Michael Zwick, Thale Jarvis, Tod Woolf, Peter Haeberli, Jasenka Matulic-Adamic
  • Deprotection of RNA
    Publication number: 20020103366
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Application
    Filed: September 21, 2001
    Publication date: August 1, 2002
    Applicant: Ribozyme Pharmaceuticals, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman
  • Deprotection of RNA
    Patent number: 6303773
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: October 16, 2001
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman
  • Method for screening nucleic acid catalysts
    Patent number: 6280936
    Abstract: Nucleic acid catalysts, method of screening for variants of nucleic acid catalysts, synthesis of ribozyme libraries and discovery of gene sequences are described.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: August 28, 2001
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Alex Burgin, Leonid Beigelman, Laurent Bellon
  • Deprotection of RNA
    Patent number: 6162909
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: December 19, 2000
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman
  • Deprotection of RNA
    Patent number: 6054576
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: April 25, 2000
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman